In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...

A new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a ...

Higher hospitalization rates were associated with several chronic conditions, possibly due to a higher likelihood of ...

On 12 March 2025, the World Health Organization (WHO) prequalified the first maternal respiratory syncytial virus (RSV) vaccine to protect infants ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

Background: Risk factors for severe respiratory syncytial virus (RSV) disease include prematurity, congenital heart disease, chronic lung disease, and immunocompromised states. There is no ...

Higher hospitalization rates were associated with several chronic conditions, possibly due to a higher likelihood of infection and increased severity of RSV disease. Blood cancer was the chronic ...

Higher hospitalization rates were associated with several chronic conditions, possibly due to a higher likelihood of infection and increased severity of RSV disease. Blood cancer was the chronic ...

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a common, contagious virus affecting the lungs and breathing ...

Through the Dren Bio deal, SNY intends to expand its immunology pipeline and establish itself as a leading immunology company ...